India set to raise red flag on Fosun-Gland Pharma deal, talks may revive with Advent News News / News 7 years ago 575 Views comments CNBC-TV18 quoting government sources said on Wednesday that the Cabinet could reject the Gland Pharma-Fosun deal on the basis of the transfer of uniqu... Read more
News Coal India#39;s subsidiary Mahanadi Coalfields staring at a penalty of Rs 20,000 crore News / News - 7 years ago
Comments